Expert Review of Clinical Pharmacology

Papers
(The TQCC of Expert Review of Clinical Pharmacology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments60
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion45
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed40
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis36
Management of polypharmacy through deprescribing in older patients: a review of the role of AI tools32
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion32
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome31
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions31
Effects of the augmentation with quetiapine or olanzapine on the metabolism of duloxetine: a retrospective analysis30
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?28
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?27
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review27
Sparsentan: a dual endothelin and angiotensin II receptor antagonist approved for IgA nephropathy26
Clinical pharmacology of antiplatelet drugs24
Reducing the risk of death – a possible outcome in COPD patients24
Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis23
The pharmacotherapeutics of sarcoidosis23
Fetal safety of medications used in treating infertility21
Treatment management for rosacea: current pharmacological and non-pharmacological options21
Dostarlimab for the treatment of advanced endometrial cancer21
Cannabidiol drug interaction considerations for prescribers and pharmacists20
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy20
Amylin analogs for the treatment of obesity without diabetes: present and future20
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection19
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trial18
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective18
Hugan tablets for the treatment of RUCAM based drug-induced liver injury: a propensity score matching analysis using a nationwide database18
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease18
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials18
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?17
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era17
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study17
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients16
Pharmacological strategies for the management of the antisocial personality disorder16
Intestinal microbiome and epilepsy: a new therapeutic approach?16
Recent pharmacological approaches for the treatment of renal cell carcinoma16
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis14
Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice14
Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis14
Hydroxyurea in the sickle cell disease modern era14
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape14
OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability14
Melflufen for the treatment of multiple myeloma14
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia13
Pediatric attention deficit hyperactivity disorder (ADHD): 2022 updates on pharmacological management13
Current status and prospects of IL-6–targeting therapy13
Clinical pharmacology of SGLT-2 inhibitors in heart failure13
Effect of laparoscopic sleeve gastrectomy on drug pharmacokinetics13
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy12
Methotrexate polyglutamates12
Methenamine Hippurate in UTI management: a reemerging pharmacological strategy12
Pharmacogenomics – a minor rather than major force in clinical medicine12
Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis11
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of adalimumab in patients with juvenile idiopathic arthritis11
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis11
Risk factors for a broken heart: understanding drug-induced causes for Takotsubo syndrome and pharmacological treatment options11
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review11
Early response is a strong predictor of the long-term response in psoriasis patients receiving risankizumab or guselkumab in the real-world: a retrospective analysis11
Efficacy and safety of tislelizumab for malignant solid tumor: a systematic review and meta-analysis of phase III randomized trials11
FLOT vs CROSS in localized esophageal adenocarcinoma: what is the current best strategy?11
A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia11
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry10
A systematic review and meta-analysis of users versus non-users: unveiling the influence of proton pump inhibitors on capecitabine efficacy in colorectal cancer10
Antimicrobial safety considerations in critically ill patients: part II: focused on anti-microbial toxicities10
Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF)10
Designer benzodiazepines: an update10
Pharmacotherapy for previously treated gastric cancer patients: current options and future developments10
Efficacy and safety of dupilumab in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis9
Signal mining study of severe cutaneous adverse events of valaciclovir or acyclovir based on the FAERS database9
Pharmacokinetic interaction of quetiapine and lamotrigine – victim and perpetrator?9
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis9
Golimumab retention in patients with psoriatic arthritis and axial spondyloarthritis: evidence from up to a decade of follow-up9
Recent advances in the pharmacological management of sepsis-associated acute kidney injury9
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review9
Revolutionizing diabetes care: unveiling tirzepatide’s potential in glycemic control and beyond9
TYK2 as a novel therapeutic target in psoriasis9
Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight9
Clinical pharmacology of siRNA therapeutics: current status and future prospects9
Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression9
Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling9
The nocebo phenomenon in the COVID-19 pandemic: a nocebodemic effect9
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database8
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan8
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations8
The future of pharmacology education: The Veterinary Educators in Pharmacology Special Interest Group (VEPSIG)8
Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegaly8
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia8
Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis8
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future8
Dasiglucagon for treating severe hypoglycemia in patients with diabetes8
Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses8
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia8
Reliance is key to effective access and oversight of medical products in case of public health emergencies8
Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury7
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock7
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective7
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to suppor7
The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective7
Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study7
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?7
Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management7
Detrimental impact of gastric acid suppressants on vascular endothelial growth factor receptor tyrosine kinase inhibitors efficacy: evidence from a systematic review and meta-analysis7
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin7
Novel and emerging treatment strategies for lupus nephritis7
Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis7
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause7
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system7
Hormonal contraception, past, present, and future part 1: the early path – facts, stories, and controversies7
Intravitreal immunotherapy in non-infectious uveitis: an update7
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants7
Considerations when prescribing opioid agonist therapies for people living with HIV7
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria7
Psychedelic drugs for the treatment of substance use disorders7
Practical challenges and considerations in adopting biosimilars in oncology clinical practice within a large healthcare system7
0.24323701858521